Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

ESMO-Virtual-Plenary-2021-1000x250px-No-Bubble

Accelerating Research to Practice

The ESMO Virtual Plenaries are monthly presentations of the latest, original scientific data from:

  • Randomized phase III trials in oncology
  • Phase II trials which demonstrate remarkable therapeutic benefit, scientific insight or progress in an area of unmet need
  • Phase I/II studies and translational research that provide impactful data on mechanisms of action, biomarkers, and novel precision oncology therapeutics
  • Real-world data series of high quality evidence on effectiveness, biomarker discovery/validation, treatment strategies, safety, resource allocation

  • Full abstract submission of original data to be presented by independent investigators, in accordance with the ESMO Congress abstract regulations.
  • Submitted abstracts to be reviewed by the ESMO Congress Scientific Chair(s), the appropriate Scientific Track Chairs and a panel of independent experts
  • Accepted abstracts will be presented and discussed during live 60-minute sessions.
  • Presented abstracts will be published in Annals of Oncology and eligible for encore presentation at the following ESMO Congress.

Join the next ESMO Virtual Plenary edition to stay up to date with the latest research in metastatic breast cancer and gastrointestinal stromal tumour (GIST):

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.